Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Hypertension. 2013 Aug 12;62(3):485–491. doi: 10.1161/HYPERTENSIONAHA.113.01608

Table 2.

Hazard ratios (95% confidence interval) relative to <1.07 METh/d for all CVD-related mortality in 10,880 runners and walkers on hypertensive medications.

Dependent variable 1.07 to
1.8 METh/d		 1.8 to
3.6 METh/d		 ≥3.6 METh/d
Ischemic heart disease
  No BMI adjustment 0.82
(0.59, 1.13)
P=0.23		 0.71
(0.54, 0.93)
P=0.01		 0.83
(0.60, 1.15)
P=0.27
  BMI adjustment 0.87
(0.62, 1.19)
P=0.38		 0.75
(0.57, 0.99)
P=0.04		 0.91
(0.65, 1.27)
P=0.59
Cerebrovascular disease
  No BMI-adjustment 0.81
(0.48, 1.32)
P=0.40		 0.45
(0.27, 0.73)
P=0.001		 0.53
(0.29, 0.94)
P=0.03
  BMI-adjustment 0.83
(0.49, 1.36)
P=0.46		 0.46
(0.28, 0.76)
P=0.002		 0.56
(0.30, 0.99)
P=0.05
Dysrhythmia
  No BMI-adjustment 0.86
(0.59, 1.21)
P=0.38		 0.53
(0.38, 0.73)
P=0.0001		 0.57
(0.38, 0.84)
P=0.004
  BMI-adjustment 0.87
(0.61, 1.24)
P=0.45		 0.54
(0.39, 0.75)
P=0.0003		 0.59
(0.39, 0.88)
P=0.009
Heart Failure
  No BMI-adjustment 0.82
(0.49, 1.31)
P=0.41		 0.49
(0.30, 0.79)
P=0.003		 0.55
(0.27, 1.01)
P=0.05
  BMI-adjustment 0.92
(0.55, 1.48)
P=0.73		 0.57
(0.35, 0.91)
P=0.02		 0.68
(0.34, 1.26)
P=0.23
Hypertensive Heart Disease
  No BMI-adjustment 1.07
(0.70, 1.61)
P=0.76		 0.72
(0.49, 1.05)
P=0.09		 0.85
(0.53, 1.34)
P=0.49
  BMI-adjustment 1.12
(0.73, 1.69)
P=0.59		 0.76
(0.51, 1.12)
P=0.17		 0.92
(0.57, 1.47)
P=0.73

Adjusted for age (age, age2), sex, education, cohort, intakes of red meat, fruit, alcohol, prior heart attack, aspirin (tablets/day), diabetes and cholesterol medication use, and African American ethnicity. Additional adjustment for BMI where indicated